Navigation Links
Grove Instruments Inc. Closes $6 M Series B Financing
Date:12/19/2011

WORCESTER, Mass., Dec. 19, 2011 /PRNewswire/ -- Grove Instruments Inc., a medical device company based in Worcester, MA developing the world's first noninvasive glucometer, today announced that The Company's $6 M Series B Preferred Stock offering closed and was oversubscribed.  "The attractiveness of this financing has been catalyzed by our technical progress and recent additions of key individuals to our Board of Directors and Scientific Advisory Board," explained Arthur Combs, Grove's CEO.

During the fourth quarter, Grove added 2 recognized leaders in diabetes care and research with William Tamborlane, MD of Yale and David Harlan, MD of  the University of Massachusetts and formerly of NIH NIDDK both joining the Scientific Advisory Board.  Most recently, Craig Mello, Ph D, Nobel Laureate and molecular biologist joined Grove's Board of Directors to assist the company's advancement.  Dr. Mello has a child with Type 1 diabetes.  "We continue to assemble a world-class Board and an unparalleled complement of Scientific Advisors.  Investors invest in people before technology," says Combs, "and our corporate governance and leadership is second to none."

Grove's technology is also a tremendous draw for the investment community. "Diabetes is now nearly ubiquitous in day to day life," noted Combs, "nearly everyone knows someone with the disease and has seen the pain, cost and long term detriment of invasive glucose monitoring.  Our value proposition – painless, bloodless and no cost per use glucose monitoring – speaks for itself." Combs went on to say "Grove is on track to produce the world's first noninvasive glucose meter that exceeds the ISO standards for all of the current [invasive, blood-based] meters, and that is very exciting."

The private placement round was completed by new investors from the greater Boston area and current shareholders.  "In the end, we were actually oversubscribed for this round," Combs said, "the combination of great people and innovative transformational technology is truly compelling."

About Grove Instruments

Grove Instruments Inc. is a privately held pre-market medical device company developing the world's first noninvasive glucometer with the potential to exceed the ISO standard for blood glucose meters.  Grove's patented technology is based on the seminal concept of the Optical Bridge and is unique among all NIR spectroscopic approaches to noninvasive blood glucose determination.  The Company has been recognized for its innovation, technology development and clinical results on 10 separate occasions by the NIH NIDDK with funded SBIR Grants. In 2011, Grove was also recognized by the Massachusetts Life Sciences Center with an Accelerator Award – one of only 4 recipients out of all Boston-area life sciences companies applying in that round.  For more information see www.groveinstruments.com or contact Arthur Combs (314 341 3444 mobile).

Forward looking statement

Certain statements contained in this plan containing words like "believe", "intend", "may", "expect", "project" and other similar expressions are forward looking statements involving a number of risks and uncertainties. Factors that can cause actual results to differ materially from those projected in the company's forward-looking statements include the following: market acceptance of our technologies, therapies, and products; our ability to obtain financing; our financial and technical resources relative to those of our competitors; our ability to keep up with rapidly changing technological; government regulations of our technologies; our ability to assert and enforce our intellectual property rights and protect our proprietary technologies; the ability to attract and retain key employees; the ability to obtain and develop partnership opportunities; the timing of commercial product launches; the ability to achieve key milestones in key products and other risks factors from time to time in the company's filings.

Contact: Arthur Combs, CEO
Cell: 314 341 3444, acombs@groveinstruments.com

 


'/>"/>
SOURCE Grove Instruments Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mangrove Partners Responds to Erroneous CPEX Assertions
2. Mangrove Partners Proposes Fully-Financed Dividend Recapitalization to Board of CPEX Pharmaceuticals, Inc.
3. Nobel Laureate to Join Grove Instruments Board of Directors
4. Study Finds Starion Instruments Tissue Welding Technology Reduces Pain and Bleeding in Tonsillectomy Patients
5. Study Finds Starion Instruments Tissue Welding Technology Safe and Effective in Parotidectomy Procedures
6. Novare Announces Completion of First Pediatric Single Port Spleen Removal Using RealHand(R) HD Instruments
7. Novare Announces Successful Series of Single Port Lap Band Procedures With RealHand(R) High Dexterity Instruments
8. Verathon(R) Helps Physicians Identify the Presence of Abdominal Aortic Aneurysms with New AortaScan(TM) Brand of Portable Ultrasound Aortic Measurement Instruments
9. Smith & Nephew Orthopaedics Begins Distribution to Haiti of Trauma Implants and Instruments
10. Millar Instruments and Harvard Apparatus Improve Ability to Provide Customers With Total Physiology Solutions Through Joint Distribution Agreement
11. ForteBio Launches New Dip and Read(TM) Residual Protein A Detection Kit; Introduces Sidekick(TM) Offline Biosensor Immobilization Station for All Octet(R) Instruments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 2016 , ... Comfort Keepers® of San Diego, CA is excited to announce ... program to drive cancer patients to and from their cancer treatments. Comfort Keepers ... of life and ongoing independence. Getting to and from medical treatments is one ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) sponsors ... on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, ... to helping service members that have been wounded in battle and their families. Venture ...
Breaking Medicine News(10 mins):